Automated in vivo screen in zebrafish identifies Clotrimazole as targeting a metabolic vulnerability in a melanoma model. [electronic resource]
Producer: 20200706Description: 215-225 p. digitalISSN:- 1095-564X
- Animals
- Animals, Genetically Modified
- Antineoplastic Agents -- pharmacology
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Cell Survival -- drug effects
- Clotrimazole -- pharmacology
- Disease Models, Animal
- Drug Screening Assays, Antitumor -- methods
- Farnesyltranstransferase -- antagonists & inhibitors
- Humans
- Melanocytes -- metabolism
- Melanoma -- drug therapy
- Miconazole -- pharmacology
- Piperidines -- pharmacology
- Pyridines -- pharmacology
- Skin Neoplasms -- drug therapy
- Zebrafish
- Melanoma, Cutaneous Malignant
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.